Conditions: Secondary Hyperparathyroidism Hemodialysis
Keywords: Secondary hyperparathyroidism Hemodialysis paricalcitol maxacalcitol
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 47
Healthy volunteers: no

Brief summary:
This study is a exploratory comparison of the efficacy and safety of paricalcitol injection with maxacalcitol injection in chronic kidney disease participants receiving hemodialysis with secondary hyperparathyroidism.

Detailed description:

Arms:
arm 1: 2 mcg adjusted by +/- 1 mcg, up to a maximum of 7 mcg, administered 3 times per week through intravenous catheter immediately before completion of dialysis arm 2: 5 or 10 mcg adjusted by +/- 2.5 mcg, up to a maximum of 20 mcg, administered 3 times per week through intravenous catheter immediately before completion of dialysis

Interventions: intervention 1: paricalcitol intervention 2: maxacalcitol
Intervention descriptions: intervention 1: Intravenous administration 3 times a week immediately before completion of dialysis intervention 2: Intravenous administration 3 times a week immediately before completion of dialysis

Protocol document: